Gw Henssler & Associates LTD Gilead Sciences, Inc. Transaction History

Gw Henssler & Associates LTD

$1.76 Billion
Q3 2024

A detailed history of Gw Henssler & Associates LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gw Henssler & Associates LTD holds 194,548 shares of GILD stock, worth $18.2 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares

194,548

Previous 198,998 2.24%

Holding current value

$18.2 Million

Previous $13.7 Million 19.44%

% of portfolio

0.92%

Previous 0.84%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$66.59 - $83.99 $296,325 - $373,755	-4,450 Reduced 2.24%	194,548 $16.3 Million
Q2 2024 Aug 01, 2024	BUY	$63.15 - $72.88 $154,212 - $177,972	2,442 Added 1.24%	198,998 $13.7 Million
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $227,338 - $277,233	3,176 Added 1.64%	196,556 $14.4 Million
Q4 2023 Jan 26, 2024	SELL	$73.27 - $83.09 $170,645 - $193,516	-2,329 Reduced 1.19%	193,380 $15.7 Million
Q3 2023 Oct 24, 2023	SELL	$73.94 - $80.67 $69,947 - $76,313	-946 Reduced 0.48%	195,709 $14.7 Million
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $25,615 - $29,217	337 Added 0.17%	196,655 $15.2 Million
Q1 2023 Apr 26, 2023	SELL	$77.31 - $88.08 $217,473 - $247,769	-2,813 Reduced 1.41%	196,318 $16.3 Million
Q4 2022 Feb 03, 2023	SELL	$62.32 - $89.47 $83,758 - $120,247	-1,344 Reduced 0.67%	199,131 $17.1 Million
Q3 2022 Nov 04, 2022	BUY	$59.54 - $68.01 $1.58 Million - $1.8 Million	26,479 Added 15.22%	200,475 $12.4 Million
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $1.12 Million - $1.26 Million	-19,409 Reduced 10.04%	173,996 $10.8 Million
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $617,253 - $773,485	10,657 Added 5.83%	193,405 $11.5 Million
Q4 2021 Jan 28, 2022	BUY	$64.88 - $73.64 $93,946 - $106,630	1,448 Added 0.8%	182,748 $13.3 Million
Q3 2021 Nov 02, 2021	SELL	$67.69 - $73.03 $765,573 - $825,969	-11,310 Reduced 5.87%	181,300 $12.7 Million
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $337,660 - $368,941	5,320 Added 2.84%	192,610 $13.3 Million
Q1 2021 Apr 28, 2021	BUY	$60.0 - $68.46 $2.52 Million - $2.88 Million	42,050 Added 28.95%	187,290 $12.1 Million
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $1.93 Million - $2.2 Million	-34,131 Reduced 19.03%	145,240 $8.46 Million
Q3 2020 Oct 22, 2020	BUY	$62.1 - $78.08 $125,752 - $158,112	2,025 Added 1.14%	179,371 $11.3 Million
Q2 2020 Jul 21, 2020	SELL	$72.34 - $84.0 $450,461 - $523,068	-6,227 Reduced 3.39%	177,346 $13.6 Million
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $186,512 - $238,895	2,978 Added 1.65%	183,573 $13.7 Million
Q4 2019 Feb 24, 2020	SELL	$61.62 - $67.78 $158,116 - $173,923	-2,566 Reduced 1.4%	180,595 $11.7 Million
Q3 2019 Nov 18, 2019	BUY	$62.51 - $69.0 $62,760 - $69,276	1,004 Added 0.55%	183,161 $11.6 Million
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $105,673 - $118,501	1,708 Added 0.95%	182,157 $12.3 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.27 Million - $1.42 Million	20,240 Added 12.63%	180,449 $11.7 Million
Q4 2018 Jan 22, 2019	SELL	$60.54 - $79.0 $1.07 Million - $1.4 Million	-17,665 Reduced 9.93%	160,209 $10 Million
Q3 2018 Oct 23, 2018	BUY	$71.28 - $78.92 $164,015 - $181,594	2,301 Added 1.31%	177,874 $13.7 Million
Q2 2018 Aug 06, 2018	BUY	$64.88 - $75.68 $309,412 - $360,917	4,769 Added 2.79%	175,573 $12.4 Million
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $24,328 - $29,659	334 Added 0.2%	170,804 $12.9 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $242,906 - $285,137	3,414 Added 2.04%	170,470 $12.2 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $12 Million - $14.3 Million	167,056	167,056 $13.5 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gw Henssler & Associates LTD with notifications on news.

Account

Gw Henssler & Associates LTD Gilead Sciences, Inc. Transaction History